Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL P RILL

Allopathic & Osteopathic Physicians Family Medicine

NPI
1861454597
CMS profile
311648
Location
GLENMOORE, PA

General Payments · PY2018–2019

$1,892.06

  • Reported across 153 records
  • CMS publication 2026-01-23

Latest program year · PY2019

$481.47

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2019 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $475.47 38
Education $6.00 1

By paying entity

PY2019 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,410.59 114
PY2019 $481.47 39

Payment records · PY2019 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2019 2018 Record-level detail is published for PY2019; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $14.09 02/07/2019 Food and Beverage Undisputed 01/23/2026 662771971 CMS
AstraZeneca Pharmaceuticals LP $14.01 01/14/2019 Food and Beverage Undisputed 01/23/2026 685440575 CMS
AstraZeneca Pharmaceuticals LP $6.00 02/28/2019 Education Undisputed 01/23/2026 685733297 CMS
AstraZeneca Pharmaceuticals LP $20.06 02/28/2019 Food and Beverage Undisputed 01/23/2026 685748431 CMS
AstraZeneca Pharmaceuticals LP $11.66 04/01/2019 Food and Beverage Undisputed 01/23/2026 685731735 CMS
AstraZeneca Pharmaceuticals LP $17.67 04/03/2019 Food and Beverage Undisputed 01/23/2026 685158937 CMS
AstraZeneca Pharmaceuticals LP $15.11 04/08/2019 Food and Beverage Undisputed 01/23/2026 685187691 CMS
AstraZeneca Pharmaceuticals LP $14.45 06/03/2019 Food and Beverage Undisputed 01/23/2026 685327203 CMS
AstraZeneca Pharmaceuticals LP $12.72 06/24/2019 Food and Beverage Undisputed 01/23/2026 685274683 CMS
Janssen Pharmaceuticals, Inc $12.58 02/05/2019 Food and Beverage Undisputed 01/23/2026 659237587 CMS
Janssen Pharmaceuticals, Inc $29.15 06/05/2019 Food and Beverage Undisputed 01/23/2026 659237589 CMS
Lilly USA, LLC $11.91 04/22/2019 Food and Beverage Undisputed 01/23/2026 658035129 CMS
Lilly USA, LLC $13.73 05/15/2019 Food and Beverage Undisputed 01/23/2026 658031939 CMS
Lilly USA, LLC $10.80 06/26/2019 Food and Beverage Undisputed 01/23/2026 658031941 CMS
Merck Sharp & Dohme Corporation $11.22 02/04/2019 Food and Beverage Undisputed 01/23/2026 695269219 CMS
Merck Sharp & Dohme Corporation $10.92 04/15/2019 Food and Beverage Undisputed 01/23/2026 695424345 CMS
Novartis Pharmaceuticals Corporation $17.36 03/21/2019 Food and Beverage Undisputed 01/23/2026 659884211 CMS
Novartis Pharmaceuticals Corporation $18.87 05/07/2019 Food and Beverage Undisputed 01/23/2026 659884207 CMS
Novartis Pharmaceuticals Corporation $11.62 06/04/2019 Food and Beverage Undisputed 01/23/2026 659884209 CMS
Novo Nordisk Inc $10.16 02/22/2019 Food and Beverage Undisputed 01/23/2026 668787273 CMS
Novo Nordisk Inc $22.87 02/25/2019 Food and Beverage Undisputed 01/23/2026 668787277 CMS
Novo Nordisk Inc $12.15 02/27/2019 Food and Beverage Undisputed 01/23/2026 668787275 CMS
Novo Nordisk Inc $1.90 02/27/2019 Food and Beverage Undisputed 01/23/2026 692235927 CMS
Novo Nordisk Inc $9.10 03/20/2019 Food and Beverage Undisputed 01/23/2026 692235929 CMS
Novo Nordisk Inc $5.67 03/20/2019 Food and Beverage Undisputed 01/23/2026 692235931 CMS
Novo Nordisk Inc $7.84 05/01/2019 Food and Beverage Undisputed 01/23/2026 692235933 CMS
Novo Nordisk Inc $4.40 05/01/2019 Food and Beverage Undisputed 01/23/2026 692235935 CMS
Novo Nordisk Inc $1.21 05/22/2019 Food and Beverage Undisputed 01/23/2026 692235937 CMS
Novo Nordisk Inc $14.98 05/22/2019 Food and Beverage Undisputed 01/23/2026 705939157 CMS
Novo Nordisk Inc $3.72 06/18/2019 Food and Beverage Undisputed 01/23/2026 692235939 CMS
Novo Nordisk Inc $19.98 06/18/2019 Food and Beverage Undisputed 01/23/2026 705940629 CMS
Novo Nordisk Inc $0.57 06/28/2019 Food and Beverage Undisputed 01/23/2026 692235941 CMS
Novo Nordisk Inc $15.16 06/28/2019 Food and Beverage Undisputed 01/23/2026 705939441 CMS
PFIZER INC. $11.97 01/30/2019 Food and Beverage Undisputed 01/23/2026 673317631 CMS
PFIZER INC. $11.52 03/13/2019 Food and Beverage Undisputed 01/23/2026 673318765 CMS
PFIZER INC. $11.70 06/10/2019 Food and Beverage Undisputed 01/23/2026 673313663 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.60 01/16/2019 Food and Beverage Undisputed 01/23/2026 682060275 CMS
Takeda Pharmaceuticals U.S.A., Inc. $0.95 01/16/2019 Food and Beverage Undisputed 01/23/2026 682076555 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.09 02/06/2019 Food and Beverage Undisputed 01/23/2026 681961407 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019
Source files
Dataset page · Bulk file · PY2018 , PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.